Skip to content
healthcare.dev

Budesonide Inhalation Suspension

NDC 69097-319, Budesonide, inhalant, from Cipla USA Inc..

Product NDC
69097-319
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
INHALANT
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205710
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-319 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUDESONIDE.5 mg/2mL

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Package NDCNDC-11Package
69097-319-536909703195330 POUCH in 1 CARTON (69097-319-53) / 1 AMPULE in 1 POUCH (69097-319-32) / 2 mL in 1 AMPULE
69097-319-87690970319876 POUCH in 1 CARTON (69097-319-87) / 5 AMPULE in 1 POUCH (69097-319-86) / 2 mL in 1 AMPULE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c52c5382-1400-44b9-95be-a30e1cf706da
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=69097-319
  • NADAC price for package 69097031953

    GET /v1/drugs/nadac/69097031953
  • NADAC price for package 69097031987

    GET /v1/drugs/nadac/69097031987

Use it

Look up 69097-319 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-319 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-319. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.